Univariate | Multivariate | Multivariate | Multivariate | Multivariate | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | (95% CI) | p-value | HR | (95% CI) | p-value | HR | (95% CI) | p-value | HR | (95% CI) | p-value | HR | (95% CI) | p-value | ||
Over 65% volume reduction at MRI evaluation | No | 1 | < 0.01 | 1 | < 0.01 | |||||||||||
Yes | 0.33 | (0.15–0.74) | 0.35 | (0.16–0.76) | ||||||||||||
Over 90% volume reduction at MRI evaluation | No | 1 | 0.03 | 1 | 0.04 | |||||||||||
Yes | 0.38 | (0.16–0.91) | 0.41 | (0.17–0.97) | ||||||||||||
each GTV (cc) | 0.3–1 | 1 | < 0.01 | 1 | < 0.01 | 1 | < 0.01 | 1 | 0.02 | 1 | 0.01 | |||||
> 1 | 4.62 | (1.56–13.68) | 4.48 | (1.50–13.37) | 4.37 | (1.48–12.88) | 3.72 | (1.28–10.83) | 4.12 | (1.39–12.25) | ||||||
Age (years) | 22–65 | 1 | 0.70 | |||||||||||||
> 65 | 0.84 | (0.35–2.00) | ||||||||||||||
PS | 0–1 | 1 | 0.17 | |||||||||||||
2–3 | 1.80 | (0.78–4.17) | ||||||||||||||
Primary cancer | Lung and breast | 1 | 0.66 | |||||||||||||
Others | 1.23 | (0.49–3.09) | ||||||||||||||
GTV dose | D80 < 42 Gy | 1 | < 0.01 | 1 | 0.01 | |||||||||||
D80 > 42 Gy | 0.27 | (0.12–0.61) | 0.37 | (0.17–0.81) | ||||||||||||
GTV dose | D98 < 39 Gy | 1 | 0.04 | 1 | 0.22 | |||||||||||
D98 > 39 Gy | 0.40 | (0.17–0.96) | 0.58 | (0.25–1.38) |